A few words from our CEO, Henny Brand
Our year in numbers
Our patients
1,448 patients were given a second chance of life
572 patient grants were provided to support patients and their families, totalling £145,473
Our register
27,607 people were recruited to the register
909,512 potential donors are now active on our register
Our supporters
£8,587,191 was raised and donated by our dedicated supporters and partners
1,109 people gave their time
to volunteer with us
Our operations
414 donors donated cells,
cord blood or cord tissue for research or for cell and gene therapy
2,610 searches for unique patients in the UK were
carried out by our Search and Selection Team
Anthony Nolan now gives four people another chance to live every day
Aim 1 : Survival
To give every transplant patient the best chance – and quality – of life
Why is this important?
Last year, the number of lifesaving matches we found for patients every day increased from three to four. This is a great achievement and means we are giving even more people another chance to live. But there is so much more to do. We know that receiving a transplant is only the beginning; we also want to improve the quality of life for patients. Over the next four years and beyond, our ambition is to ensure more patients not only survive but also thrive after a transplant.
We are striving to improve access to treatments and support to all patients and their loved ones by:
- Growing our register of lifesaving donors
- Providing specialist support
- Conducting research to improve the effectiveness of transplant
- Influencing policy and practice.
We are dedicated to continuing to recruit people from
minority ethnic backgrounds
Aim 2 : Equity
To ensure all patients have the best access to, experience of and outcome from, treatment
Why is this important?
We know that many factors influence a patient’s access to, experience of, and outcome from treatment, including ethnicity, socioeconomic status, education, geographical location, knowledge of the healthcare system, and many more. It is important that we understand how and why disparities happen, and how we can tackle them so that we can help to remove these barriers to care, creating treatments and services that are equally effective and accessible to all.
There are still people, particularly those from minority ethnic backgrounds, for whom it is harder to find the best possible matching unrelated donor. That’s why we are:
- Investing in strengthening the global pool of donors
- Supporting and maintaining our cord blood bank (as cord blood requires less precise matching)
- Researching new cell therapies and medicines that could mean full matching becomes less important.
We believe in a future where all patients have timely access to cutting-edge cell therapies and personalised care
Aim 3 : Progress
To explore and embrace new cell therapies and make them available for patients more quickly
Why is this important?
New cell therapies have the potential to transform the outcomes of many diseases, including blood cancers and blood disorders. It is vital that we continue our research into new cell treatments and our
influencing efforts to improve their availability and accessibility, so that more patients can benefit. These therapies could provide a bridge to a stem cell transplant or eliminate the need for one altogether for
some patients. Donors will play a key role, but their cells will help in a different way – not just to save individual lives, but also to facilitate the research that could save multiple lives in the future.
We will do this by:
- Encouraging more donors to contribute their cells for research into new treatments
- Use our expertise, products and services to drive forward research, development and manufacture of new treatments.
- Shape every patient’s treatment, care and support by their individual needs and experiences.
All thanks to you
Everything we have achieved, and everything we plan to achieve in the future, is only made possible thanks to people like you. We are so grateful for the continued support of the many volunteers, partners, funders, supporters, individuals, families and organisations that work with us to change lives.
A special thank you to the organisations and individuals listed here
- Adrian Sudbury Schools Education Trust
- African Caribbean Leukaemia Trust
- Anna Marie McGinty Scanlon
- Autolus Therapeutics
- Aventis Pharma Limited (Sanofi)
- Daniel Horton
- Dig Deeper: The Construction Industry
- Adventure Race
- Duncan Fawcett
- Family and friends of Eesa
- Garfield Weston Foundation
- Gilead Sciences Limited
- Gilly’s Gang
- Greater Manchester Fire and Rescue Service
- Hugh Fraser Foundation
- Humberside Police
- Jack Petchey Foundation
- Janus Henderson
- Lactalis UK & Ireland and Lactalis Nestlé Chilled Dairy
- Lera Zenko
- Louie Martin and the Wacky Racers Coffee Club
- Marrow
- Members of the National BAME Transplant Alliance
- Neil’s Day committee
- NEXT
- One Voice Blackburn
- PF Charitable Trust
- Philip Powell
- Police Scotland
- Race Against Blood Cancer
- RSM UK Foundation
- Scottish Fire and Rescue Service
- Takeda UK Limited
- The Ammies
- The Securities Finance Ball
- The Sue Harris Trust
- The Family & Friends of Olly Wilkes
- The Friends of Anthony Nolan
- Therakos UK